SCHEDULE 13D

Company

Enveric Biosciences, Inc.

Filed

December 4, 2013

Accession Number

0001248915-13-000154

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →